Notice Number: NOT-CA-16-044
Key Dates
Release Date: June 15, 2016
PAR-15-331
Issued by
National Cancer Institute (NCI)
Purpose
This Notice amends the Eligibility Information and Application and Submission Information and Additional Review Considerations sections of PAR-15-331 "Advanced Development of Informatics Technologies for Cancer Research and Management (U24)".
The following sections have been modified (in italics):
Part 2. Section III. Eligibility Information
1. Eligible Applicants
Foreign Institutions
Current language:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Modified language (in italics):
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Section IV. Application and Submission Information
Foreign Institutions
Current language:
(No text)
Modified language:
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.
Section V. Application Review Information
Additional Review Considerations
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Applications from Foreign Organizations
Current language:
Not applicable.
Modified language:
Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
All other aspects of the FOA remain the same.
Inquiries
Please direct all inquiries to:
Juli Klemm, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-480-5778
Email: juli.klemm@nih.gov
and Human Services (HHS)
